Community-acquired pneumonia and sepsis caused by a multiresistant Staphylococcus Aureus strain resulting in a severe and long-lasting multiple organ inflammatory involvement

European Journal of Inflammation

Volumn 4, Issue 2, 2006, Pages 117-123

  Sabbatani, S ^a   Manfredi, Roberto ^a   Marinacci, G ^a   Chiodo, F ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Hepato splenic dissemination; Immune activation; Methicillin resistance; Multiple thrombophlebitis; Myocarditis pericarditis; Pleural effusion; Pneumonia; Sepsis; Staphylococcus aureus

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; FLUCONAZOLE; GENTAMICIN; HEPARIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MACROLIDE; METHYLPREDNISOLONE; METICILLIN; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TIMENTIN;

ADULT; ANEMIA; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BRONCHOSCOPY; CASE REPORT; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DISEASE SEVERITY; DYSPNEA; ECHOGRAPHY; FATTY LIVER; FEVER; FOLLOW UP; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LABORATORY TEST; LIVER BIOPSY; LUNG INFILTRATE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIPLE ORGAN FAILURE; MYOCARDITIS; PATHOGENESIS; PATIENT CARE; PERICARDIAL EFFUSION; PERICARDITIS; PLEURA EFFUSION; SEPSIS; THROMBOPHLEBITIS; THROMBOSIS;

EID: 33748274897     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X0600400206     Document Type: Article

References (29)

1. Decousser J.W., P. Pina, F. Picot, C. Delalande, B. Pangon, P. Courvalin and P. Allouch. 2003. Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey. J. Antimicrob. Chemother. 51:1213.
2. Stefani S. and P.E. Varaldo. 2003. Epidemiology of methicillin-resistant staphylococci in Europe. Clin. Microbiol. Infect. 9:1179.
3. Manfredi R., A. Nanetti, R. Valentini, L. Calza and F. Chiodo. 2002. A prospective surveillance study of methicillin resistance levels of Staphylococcus aureus strains isolated in selected high-risk wards of a large tertiary care Hospital. Infect. Dis. Clin. Pract. 11:427.
4. Berger-Bachi B. and S. Rohrer. 2002. Factors influencing methicillin resistance in staphylococci. Arch. Microbiol. 178:165.
5. Pistella E., F. Campanile, D. Buongiorno, S. Stefani, G.D. Di Nucci, P. Serra and M. Venditti. 2004. Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus endocarditis unresponsive to vancomycin therapy with linezolid. Scand. J. Infect. Dis. 36:222.
6. Turnidge J. 2003. Impact of antibiotic resistance on the treatment of sepsis. Scand. J. Infect. Dis. 35:677.
7. Moyenuddin M., C.A. Ohl, J.C. Williamson and J.E. Peacock. 2003. Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy. J. Antimicrob. Chemother. 51:202.
8. Manfredi R., S. Sabbatani and F. Chiodo. 2005. Severe staphylococcal knee arthritis responding favorably to linezolid after glycopeptide-rifampicin failure. A case report and literature review. Scand. J. Infect. Dis. 37:513.
9. Manfredi R. 2005. A re-emerging class of antimicrobial agents: streptogramins (quinupristin/dalfopristin) in the management of multiresistant gram-positive nosocomial cocci in hospital setting. Mini Rev. Med. Chem. 5:1075.
10. Melzer M. S.J. Eykyn, W.R. Gransden and S. Chinn. 2003. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin. Infect. Dis. 37:1453.
11. Healy C.M., D.L. Palazzi, M.S. Edwards, J.R. Campbell and C.J. Baker. 2004. Features of invasive staphylococcal disease in neonates. Pediatrics 114:953.
12. Raja Lope RJ., A.R. Goldstein and J.W. Gray. 2004. Delayed disseminated Staphylococcus aureus infection following chickenpox. J. Paediatr. Child Health 40:320.
13. Liao C.H., T.C. Yao, H.T. Chung, R.I. Lien and J.L. Huang. 2004. Staphylococcal endocarditis and multiple emboli in a patient with systemic lupus erythematosus. J. Rheumatol. 31:2305.
14. Weitz G., H. Djonlagic, P. Montzka, J. Steinhoff and C. Dodt. 2000. Toxic shock syndrome with multi-organ involvement. Dtsch. Med. Wochenschr. 125:1530.
15. Floret D. 2001. Clinical aspects of streptococcal and staphylococcal toxinic diseases. Arch. Pediatr: (S)8:762.
16. Hamidou M. and C. Belizna. 2003. Superantigens and vasculitis. Ann. Med. Interne (Paris) 154:96.
17. Amagai M. 2003. Desmoglein as a target in autoimmunity and infection. J. Am. Acad. Dermatol. 48:244.
18. Krakauer T. 1999. Immune response to staphylocococcal superantigens. Immunol. Res. 20:163.
19. Proft T. and J.D. Fraser. 2003. Bacterial superantigens. Clin. Exp. Immunol. 133:299.
20. Stohl W., D. Xu, S. Zang, K.S. Kim, L. Li, J.A Hanson, S.A. Stohlman, C.S. David and C.O. Jacob. 2001. In vivo staphylococcal superantigen-driven polyclonal Ig responses in mice: dependence upon CD4+ cells and human MHC class II. Int. Immunol. 13:1291.
21. Carulli G., G. Lagomarsini, A. Azzara, R. Testi, R. Riccioni and M. Petrini. 2004. Expansion of TcRalphabeta+CD3+CD4-CD8- (CD4/CD8 double-negative) T lymphocytes in a case of staphylococcal toxic shock syndrome. Acta Haematol. 111:163.
22. Tomita H., M. Yamada, I. Sekigawa, T. Yashiike, N. Iida and H. Hashimoto. 2003. Systemic lupus erythematosus-like autoimmune abnormalities induced by bacterial infection. Clin. Exp. Rheumatol. 21:497.
23. Yokota N., H. Morita, S. Iwasaki, H. Ooba, T. Ideura and A. Yoshimura. 2001. Reversible nephrotic syndrome in a patient with amyloid A amyloidosis of the kidney following methicillin-resistant Staphylocococcus aureus infection. Nephron 87:177.
24. Nasr S.H., G.S. Markowitz, J.D. Whelan, J.J. Albanese, R.M. Rosen, D.A. Fein, S.S. Kim and V.D. D'Agati. 2003. IgA-dominant acute poststaphylococcal glomerulonephritis complicating diabetic nephropathy. Hum. Pathol. 34:1235.
25. Pola E., G. Logroscino, V. De Santis, F. Canducci, A. Delcogliano and A. Gasbarrini. 2003. Onset of Berger disease after Staphylococcus aureus infection: septic arthritis after anterior cruciate ligament reconstruction. Arthroscopy 19:29.
26. Koyama A., S. Sharmin, H. Sakurai, Y. Shimizu, K. Hirayama, J. Usui, M. Nagata, K. Yoh, K. Yamagata, K. Muro, M. Kobayashi, K. Ohtani, T. Shimizu and T. Shimizu. 2004. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int. 66:121.
27. Sharmin S., Y. Shimizu, M. Hagiwara, K. Hirayama and A. Koyama. 2004. Staphylococcus aureus antigens induce IgA-type glomerulonephritis in Balb/c mice. J. Nephrol. 17:504.
28. Visser L., H. Jan de Heer, L.A. Boven, D. Van Riel, M. Van Meurs, M.J. Melief, U. Zahringer, J. Van Strijp, B.N. Lambrecht, E.E. Nieuwenhuis and J.D. Laman. 2005. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease. J. Immunol. 174:808.
29. Ruiz-Ruiz F.J., B. Martin Lorenzo, A. Amores Arriaga, F.J. Ruiz Laiglesia, A.M. Hualde Enguita and J.L. Perez Calvo. 2004. Acute transverse myelopathy associated to S. aureus: a difficult differential diagnosis. Neurologia 19:130.